The Wayback Machine - https://web.archive.org/web/20120223232358/https://en.wikipedia.org/wiki/GSK1360707F

GSK1360707F

From Wikipedia, the free encyclopedia
Jump to: navigation, search
GSK1360707F
Systematic (IUPAC) name
(1R,6S)-1-(3,4-dichlorophenyl)-6-(methoxymethyl)-4-azabicyclo[4.1.0]heptane
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
ATC code  ?
PubChem CID 24802841
Chemical data
Formula C14H17Cl2NO 
Mol. mass 286.196 g/mol
SMILES eMolecules & PubChem
 YesY(what is this?)  (verify)

GSK1360707F is a new and potent selective triple reuptake inhibitor.[1][2]

This research chemical is still relatively new so no details are available for it as of yet.

[edit] Synthesis

GSK1360707F synthesis.png

  1. BOC Protecting group.
  2. Enolization and trapping with triflate group.
  3. Suzuki reaction
  4. Reduction
  5. Trifluoroacetic acid (TFA) removal of protecting group.
  6. Simmons–Smith reaction cyclopropanation.
  7. Williamson ether synthesis.

[edit] References

  1. ^ Micheli, F.; Cavanni, P.; Andreotti, D.; Arban, R.; Benedetti, R.; Bertani, B.; Bettati, M.; Bettelini, L. et al (2010). "6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor". Journal of Medicinal Chemistry 53 (13): 4989–5001. doi:10.1021/jm100481d. PMID 20527970.  edit
  2. ^ Deschamps, N. M.; Elitzin, V. I.; Liu, B.; Mitchell, M. B.; Sharp, M. J.; Tabet, E. A. (2010). "An Enyne Cycloisomerization Approach to the Triple Reuptake Inhibitor GSK1360707F". The Journal of Organic Chemistry 76 (2): 101221161656011. doi:10.1021/jo102098y. PMID 21174473.  edit
Personal tools
Namespaces
Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Morty Proxy This is a proxified and sanitized view of the page, visit original site.